Trinity Biotech

TRIB | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.40

+$0.05 (+0.68%)

Sep 22, 2026, 10:44 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	43.79M	61.56M	56.83M	62.52M	81.15M	101.98M
Cost of Revenue	26.9M	40.11M	37.38M	52.73M	54.89M	53.4M
Gross Profit	16.89M	21.44M	19.45M	22.05M	33.45M	48.58M
Operating Income	-11.42M	-21.17M	-27.05M	-15.27M	3.94M	82K
Interest Income	221K	n/a	1.17M	303K	1.22M	36K
Pretax Income	-37.18M	-30.73M	-36.93M	-43.78M	-1.92M	-6.63M
Net Income	-37.38M	-31.79M	-24.02M	-41M	875K	-6.39M
Selling & General & Admin	24.67M	28.82M	31.15M	29.17M	24.68M	25.07M
Research & Development	3.63M	4.54M	4.38M	4.14M	4.5M	5.08M
Other Expenses	n/a	9.25M	10.96M	-343K	336K	18.34M
Operating Expenses	28.3M	42.61M	46.5M	32.96M	29.52M	48.5M
Interest Expense	13.11M	9.57M	10.15M	24.73M	7.1M	6.75M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	55.2M	82.72M	83.88M	81.87M	77.21M	101.9M
Income Tax Expense	199K	486K	-59K	-194K	-74K	-620K
Shares Outstanding (Basic)	619.19K	598.65K	255.17K	224.9K	139.34K	139.34K
Shares Outstanding (Diluted)	619.19K	598.65K	255.17K	259.16K	177.53K	139.34K
EPS (Basic)	-60	-52.98	-96	-180	6.30	-46.14
EPS (Diluted)	-60	-52.98	-96	-156	4.92	-46.14
EBITDA	-21.38M	-16.91M	-24.1M	-16.71M	10.59M	3.2M
EBIT	-24.06M	-18.77M	-25.87M	-19.05M	7.85M	118K
Depreciation & Amortization	2.68M	1.87M	1.78M	2.33M	2.74M	3.08M